0001104659-24-031999.txt : 20240307 0001104659-24-031999.hdr.sgml : 20240307 20240307185757 ACCESSION NUMBER: 0001104659-24-031999 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240305 FILED AS OF DATE: 20240307 DATE AS OF CHANGE: 20240307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Raifeld Pavel CENTRAL INDEX KEY: 0001813426 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 24731885 MAIL ADDRESS: STREET 1: 1350 OLD BAYSHORE HIGHWAY, SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Innoviva, Inc. CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1350 OLD BAYSHORE HIGHWAY STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 6502389600 MAIL ADDRESS: STREET 1: 1350 OLD BAYSHORE HIGHWAY STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: THERAVANCE INC DATE OF NAME CHANGE: 20020207 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 4 1 tm248180-3_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-03-05 0 0001080014 Innoviva, Inc. INVA 0001813426 Raifeld Pavel 1350 OLD BAYSHORE HIGHWAY, SUITE 400 BURLINGAME CA 94010 0 1 0 0 Chief Executive Officer 0 Common Stock 11666 D Non-statutory Stock Option 14.88 2024-03-05 4 A 0 75000 0 A 2025-02-20 2034-03-05 Common Stock 75000 575000 D Non-statutory Stock Option 18.00 2024-03-05 4 A 0 100000 0 A 2025-02-20 2034-03-05 Common Stock 100000 675000 D Non-statutory Stock Option 20.00 2024-03-05 4 A 0 150000 0 A 2025-02-20 2034-03-05 Common Stock 150000 825000 D Includes 1,867 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan on May 15, 2023. 25% of the options will vest on February 20, 2025 and the balance will vest in twelve (12) substantially equal installments thereafter on each three (3) month anniversary of the initial vesting date, in each case, subject to Mr. Raifeld's continuous service through the applicable vesting date, with accelerated vesting (i) in the event of a "change in control" (as defined in the Issuer's 2012 Equity Incentive Plan) in which the options are not assumed or replaced, or (ii) in the event that Mr. Raifeld experiences a termination of employment by the Innoviva, Inc. without "cause" or by Mr. Raifeld for "good reason" (each as defined in Mr. Raifeld's employment agreement) within 24 months following a "change in control," subject to an effective release of claims. /s/ Pavel Raifeld 2024-03-07